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leads in this development and really it is up to us to make sure 
that we get a broad enough understanding to maintain the 
support for this technology, to move it ahead with res-
ponsibility. 
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Biotechnology: The Public Concerns 
ROBERT L. SINSHEIMER 
Robert L. Sinsheimer is Chancellor of the University of California at Santa Cruz. 
Knowledge is power. Never has that been truer than in 
today's information age, with the exponential increase in 
human knowledge, with our ever more powerful computing 
devices, and with our extraordinary means of communication. 
"Give me a place to stand and I will move the earth," said 
Archimedes. Today we know that the place to stand is at the 
console of a supercomputer. 
The other side ofthe coin, and there are always two sides, is 
to be found in Ecclesiastes; "He that increaseth knowledge, 
increaseth sorrow." The author of Ecclesiastes was not simply 
being morose or jaundiced. He knew that with increased 
knowledge inevitably comes increased responsibility, for 
good or for evil; together with the increased burden of deci-
sion; the wider potential for error; and the need for new 
ethical guidelines to define the boundaries of action in the 
new domain, wrested from the realm of innocence and ignor-
ance. 
Today we are at the verge of a most extraordinary advance in 
human knowledge, in the domain of the life sciences. We are 
about to achieve no less than a complete knowledge and 
understanding of the nature of life and the plan of evolution-
and thereby of ourselves-as a part of life, a product of evolu-
tion. 
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The science of biology, in its continuing analysis of the 
processes oflife, has penetrated to life's innermost secret-to 
the genes, to DNA, to the master programs that define the 
nature of each living cell and each living organism. 
The genetic programs are carried on the chromosomes in 
the structure of very long DNA molecules. The DNA molecules 
are the well-known double helixes composed of a ladder of 
nucleotide pairs. There are four kinds of pairs and their 
sequence conveys the hereditary information. A gene is a tract 
of several hundred or several thousand such pairs and is 
located in a particular region on a particular chromosome. 
We have already determined the complete genetic struc-
ture, the DNA sequence, of a few very simple organisms (up to 
170,000 nucleotide pairs) , and we now have the capacity and 
are setting out to determine the complete genetic structure of 
higher organisms and specifically, of man. A project is now 
being launched to sequence the entire human genome, some 
3 billion nucleotide pairs of DNA. It can surely be done. It is 
only a matter of time and efficient approach (1). 
This knowledge would permit a complete enumeration of 
the genetic ingredients of man. We estimate there are 100-
300,000 genes in Homo sapiens. These will now be defined 
and enumerated. 
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I think this is a historic event comparable in significance to 
the formulation of the periodic table by Mendeleev. The 
periodic table not only ordered the elements in a rational 
manner, it also permitted us to say that this is the complete 
roster. There are no more. All objects on earth are made out of 
just 92 elements, in varied combination. 
We are, of course, still exploring unusual properties of 
novel combinations of these elements, as in the supercon-
ducting ceramics discovered recently. 
Similarly, we will, before too long, be able to say this roster 
is the complete list of human genes, or, similarly, the com-
plete list of chimpanzee genes, or mouse genes, or mosquito 
genes. This is what it takes to make a man, or a mouse, or a 
mosquito. No more, no less. 
But even more will emerge from this knowledge. The 
process of evolution and the progressive emergence of the 
panoply of organisms on earth has involved successive 
changes and divergence of genes, and particularly, of the 
genes that determine the patterns of developmental growth 
that lead to each organismic form. The old and partially true 
epigram, "Ontogeny recapitulates phylogeny," recognized 
that the developmental stages of the more recently evolved 
life forms incorporate discernible elements of the develop-
mental stages of older forms. 
Knowledge of the genetic bases of the evolution of these 
developmental patterns will enable us to classify them, to see 
how older patterns were modified and adapted to create new 
patterns, which, in turn, afforded new potentials for modifica-
tion and evolution. It is likely that we will be able to define a 
set of general patterns on which nature has worked innumer-
able variations to create the world of life. 
As knowledge, as intellectual achievement, this is a splen-
did prospect; exciting, even thrilling. But as we have repeat-
edly seen, such knowledge brings responsibility for its use. 
What uses may we envision and what dilemmas will they 
pose? 
The potentials for the use of this knowledge seem limited 
only by the range of our imagination. Consider what already in 
a few short years has been accomplished or is in process (2): 
Microorganisms that produce insulin or human growth 
hormone, or blood clotting factors that produce Vitamin C 
and by a new pathway that can protect plants against frost 
Microorganisms that make proteins for use as vaccines for 
viral disease, or novel synthetic antibodies to fight viral 
infection 
Plants that are more resistant to herbicides, plants that are 
toxic to their usual insect predators, plants of higher human 
nutritive value 
Plants more resistant to drought, or high salinity, or disease 
Farm animals that grow faster and larger and more effi -
ciently and are more resistant to disease 
Tests for genetic defect in humans for the mutations that 
lead to Huntington's Disease, or Gaucher's Disease or reti-
noblastoma 
Incipiently, efforts to develop genetic therapies for some of 
the more than 2,500 known genetic disorders that afflict 
humans (3) 
And these developments, all now in laboratory or produc-
tion phase, are but the leading edge of the new biotechnol-
ogy. In one sense, this new advance is even more powerful 
than that of Mendeleev, for we can not only invent and explore 
new combinations of genes, as we can with chemical ele-
ments , but we can also invent wholly new genes never before 
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seen to produce new molecules with novel, desired proper-
ties. 
And so looking ahead we can foresee other technologies; 
e.g., protein engineering-the design of protein molecules 
that catalyze reactions unknown in nature or under conditions 
of temperature or pH or solvent unfamiliar to living cells ( 4). 
Most of the chemical processes that underly life are very old 
in the evolutionary sense. Nature long ago devised the basic 
protein structures that efficiently carry out these processes. 
More recently invented biological processes frequently use 
protein catalysts derived by genetic mutation or rearrange-
ment from the older forms. As one result, we can see clear 
relationships between the protein molecules that react with 
oxygen or detect light in the most primitive organisms and the 
more advanced forms. And, for instance, molecules that act as 
hormones in insects are used with some modification for 
other hormonal processes in mammals (5). 
But the potential number of varieties of protein molecules, 
composed as they are of several hundred amino acids of 20 
different kinds, is literally astronomical. Only a minute frac-
tion can ever have been tried, even in the whole course of 
evolution. And so the potential for the design of genes for, and 
the synthesis of, proteins with specific novel properties would 
seem almost unlimited. 
On another scale of organization, the basic plans of living 
organisms, their structural and functional characters, have 
evolved by mutation and by rearrangements not yet well 
understood from those of the simpler forms-the worms and 
insects and echinoderms-to those of the more complex-
the fish, the reptiles, the birds and mammals. And, analo-
gously, from the simpler to the more complex plants. 
But again, there is little reason to believe that nature has 
explored the whole potential range of life forms. The forms 
nature has created had to evolve by small steps from previous 
forms, and had always to survive in the biosphere then extant. 
The forms with which we interact in a major way-the agricul-
tural plants and animals, the fish and the forests, our pets-are 
those that nature evolved and which we have adapted with 
minor modifications from the wild forms. 
But there would seem to be no reason why, with sufficient 
understanding, we could not, for instance, evolve plants more 
suited to our needs that may look nothing like wheat or corn 
or rice, or that may grow under conditions unsuited to current 
crops. Perhaps one might call this species engineering. 
But again, we have learned that the introduction of such 
profound technological change is never simple. That major 
innovations strain the resilience of our social institutions as 
these struggle to cope and adapt, as well as the resilience of 
the biosphere on which we all depend. That one must expect, 
and prepare for, accompanying economic and cultural uphea-
vals, and even for deep moral and ethical dilemmas as our 
powers increase. 
What are the public concerns? More systematically and very 
broadly, these issues, these problems can be subsumed into 
four general categories of concern: 
1. The concern of providing for equity, for social justice, while 
at the same time providing the possibility of change and 
innovation. 
2. The concern that we may, inadvertently, do ourselves some 
irreversible harm. Confronting irreversible processes is 
always a difficult task for mortal beings. 
3. Concerns relating to resolving the dilemmas of partial 
knowledge, again a perennial task for Homo sapiens. 
4. lastly, more inchoate but deeply felt, a concern for hubris, 
for the need to recognize our human limitations. 
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Concern for Equity 
Social and economic issues are already nigh upon us in 
various areas. 
The prospect of more abundant, more nutritio~s crops: of 
cattle that produce more milk, of more disease-resistant swme 
and chickens, is, of course, pleasing. But in our era of agricul-
tural overabundance, the prospect of yet more brings with it 
the prospect of yet more economic and social upheaval; of 
fewer farms and farmers ; of the survival of the larger farms 
better able to incorporate the new technology ( 6). Of course, 
new alternative jobs would be simultaneously created in the 
biotechnology industry, but the economic dislocations are 
evident and potentially immediate. 
These problems are not unique to biotechnology. But we 
are now more aware that developments that may be of great 
overall societal benefit may impose significant cost upon 
some individuals, and we increasingly recognize that they 
should not have to bear that cost alone. 
Questions already arise as to the ownership of the products 
and the profits of the new technology. Courts have already 
authorized patents for microorganisms and plants. In a logical 
extrapolation, more than a dozen applications to patent anim-
als have been filed with the patent office (7). Can a line be 
drawn should a line be drawn, as to what can be patented, 
what ~an be privatized? What are the consequences of "vali-
dating new areas of the natural world a.s private property?", to 
use Martin Kenney's phrase (8). 
Most of the fundamental research that underlies the bur-
geoning biotechnology was funded by the federal govern· 
ment in our universities and medical schools. How then 
should the financial rewards of this multi-year investment be 
distributed? 
The impact ofthe abrupt emergence ofbiotechnology from 
the academic laboratory to the industrial plant has brought 
new associations and new possibilities to the university, 
which have strained its traditional social relationships. Con-
cerns over the private use of public facilities, over the intro-
duction of industrial secrecy into academic discussion, over 
the reorientation of research objectives to profit-making goals, 
have been hotly, if inconclusively, debated. 
More broadly, and reflective of the scope and scale and 
potential of this technology, and these attendant concerns, 
one may ask, to quote again Mr. Kenney, "should the enor· 
mous power of transforming life forms be transferred to 
groups merely seeking a return on an investment?" 
Concerns about Irreversible Harm 
Human beings, at least those who reach maturity, know 
they are fallible . And thus, we have a hard time dealing with 
issues of irreversible processes. Witness our intense concern 
over such matters as the death penalty, or over the adequate 
education of our children, or more mundanely, over the loss 
of topsoil. Mistakes in such matters can never be undone. 
Biotechnology, more than other technologies, similarly 
raises the issues and concerns of irreversible processes. If we 
introduce a new chemical into the biosphere, for instance, the 
chlorofluorocarbons, and it proves to have unfortunate, unan-
ticipated consequences, as in the thinning of the ozone layer, 
we can cease its production. And in time, hopefully in ade-
quate time, it will be degraded and disappear. . 
But a living organism is by definition self-reproducmg. 
Many of the proposed applications of the biotechnology 
require that the new organisms be taken out ofthe laboratory 
and applied in the field. If these organisms thus released find a 
suitable ecological niche, reproduce and spread, they are, 
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manifestly, beyond recall. Should they prove a potential 
hazard, we have a problem. 
Opinions differ widely as to our ability to ~redi~t the o~t­
come of such introductions. The molecular b10logtsts are, m 
general, much more sanguine than the ecologic~! fraternity 
(9) . Molecular biologists argue that most genetiC changes, 
most mutations, are deleterious to the well balanced, well 
adapted genomes that nature has evolved. Most introduced 
forms will therefore be at a disadvantage in nature, and pre-
sumably, therefore only maintained by purposeful human 
intervention. They argue that pathogenicity to man or to other 
plants or animals is a complex property not likely to be 
engendered by a few genetic modifications. And ~hey argue 
that many of these modifications must have been tned already 
by nature in the course of evolution, but failed to survive. 
Ecologists are much less confident (10, 11). They are con-
cerned with the complex, often delicate ecological balances 
in nature. Microorganisms, plants, and animals each play 
essential roles in the maintenance of the biosphere. Ecolo-
gists cite examples of the devastation wrought by the intro-
duction of alien species into an apt environment, such as the 
gypsy moth, or the kudzu grass. They also cite instances 
wherein single gene mutations have markedly broadened the 
host range of undesired organisms as in the spread of cheat-
grass to rangelands, or the apple maggot, which was originally 
restricted to the Hawthorne. 
In general, ecologists are not persuaded by the molecular 
biologists' argument of optimal adaptation. They propose that 
species are individualistic, not part of a tightly woven ne.twork. 
To quote Philip Regal, "organisms are adequately, not tdeally 
constructed for survival" (12). 
Ecologists are more aware of the complexity of the prob-
lem. In a study of the consequences of the 913 species in~ro­
duced into California, 788, that is 86%, caused no ecologtcal 
damage. More than 23 species, 2.5%, however, had major 
ecological impacts. . . 
To quote Professor Wingard, "Ecology lacks general pnnct-
ples, grand theory, and laws that would enable us t~ make any 
predictions or deduce, a priori, any degree ~f certamty, ab~~t 
what the impact of any introduced speCies, whether tt s 
recombinant or not, would be in the environment" (12). 
Clearly there is a dilemma here: the problem ofthe indefin-
ably small risk of an indefinably large catastrophe. One 
approach to this issue is to be cautious, to analyze each such 
introduction on a case-by-case basis, and gradually to accumu-
late sufficient case history to permit widening generalizations. 
With some exceptions, this is the general practice. 
Elsewhere, I suggested an alternative procedure, which 
would be deliberately to build into all novel organisms a 
susceptibility to some, unnatural, chemical or physical agent, 
so that a new form could be controlled if it turned out to have 
undesirable properties. ln short, a mechanism similar to the 
abort devices we build into our rockets. This suggestion has 
not met with great acclaim, however. 
One must point out here that, of course, evolution and 
natural selection have not stopped. We are proposing greatly 
to accelerate these processes in selected domains. But the 
organisms we generate and release into the en:ironment w~ll 
then be subject to their own evolution over ttme. They wtll 
follow their own genetic destiny. 
Concerns about Partial Knowledge 
As human beings, we are continually obliged to make 
decisions, to act upon the basis of partial knowledge, and to 
improvise partial solutions, which often give rise to severe 
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issues of policy and ethics. 
Nowhere is this more evident than in medicine. We 
invented the costly technology of iron lungs and associated 
care facilities, now obsolete, to help polio victims because we 
did not know how to produce a vaccine. 
Currently, we have a costly network of treatment centers to 
provide kidney dialysis because we do not know how to repair 
damaged kidneys. This technological advance has created the 
problem of provision of the resources for this continuing, 
life-essential process, which is often beyond the means of 
many individuals. In a rich country such as the United States, 
the government assumes this responsibility, but not all coun-
tries have this capability. 
Because we do not yet know how to repair damaged organs, 
we have developed techniques of organ transplant with a 
considerable degree of success. But there is a shortage of 
organs to transplant and the cost is very high, which raises 
ethical dilemmas-who shall be the recipients and who shall 
pay? 
A5 biological knowledge advances, step by step, similar 
dilemmas of partial knowledge inevitably arise. We have, in 
recent years, greatly expanded our understanding of the 
genetic basis of many human disorders, and our ability to 
detect the presence, at the gene level , of genetic defect, 
without, at the same time, having any ability to remedy such a 
defect. 
What shall we do with this expanded capability of genetic 
foreknowledge? At present, our capabilities are limited to the 
simple genetic disorders: Huntington's Disease, Gaucher's 
Disease, sickle cell anemia. Does the child with Huntington's 
gene want to know that at age 40 he or she will begin to 
degenerate rapidly? Perhaps not, but then such knowledge 
might influence his or her reproductive decisions. 
If someone is found to be a carrier of Gaucher's Disease, 
should their kin, also potential carriers, be tested or be noti-
fied? Should in time each of us have a genetic pedigree? 
As our knowledge progresses, so will our ability to antici-
pate the more complex genetic disorders; the tendencies to 
diabetes, heart disease, schizophrenia, even the behavioral 
traits such as Alzheimer's disease, the tendency to manic 
depression or to alcoholism, or susceptibility to drug addic-
tion. 
And Jagging behind, but sure to follow in time, will be 
potential therapies for these genetic conditions. Given their 
social and economic costs, there will be great pressure for the 
application of such therapies. And therewith arises the spectre 
of human genetic engineering, and the social determination 
of genetically desirable-or undesirable-traits. 
Current policy would restrict genetic therapy to the somatic 
level for the treatment of the affected individual, and pros-
cribe intervention in the human germ line (13). Whether such 
a policy will be sustainable when the potential for interven-
tion is real, not merely hypothetical, remains to be seen. It is 
not hard to envision the commercial applications, the interna-
tional genetic rivalries, etc. 
Concern for Hubris 
And last, hubris. To the Greeks, hubris characterized those 
actions of man when he tried to set himself among the Gods. 
Today we would characterize hubris differently, as the failure 
to recognize human fallibility; the willful neglect of the limits 
of human knowledge, however rapidly expanding; the blind-
ness to our growing ability to do ourselves mortal harm as it 
parallels our growing ability to accomplish great goods. 
Some deride the very concept of hubris as one of faint heart. 
Volume 53, Number 1, 1987/ 88 
Others feel that the concept has innate human wisdom. We 
know to our cost the unhappy ends to which other great 
advances of knowledge have been put by human failings . 
The universality of the genetic structures and the code, the 
underlying similarity of the basic genetic and enzymatic pro-
cesses in all living organisms, indicate clearly that all extant 
life forms derive from a common origin. And thus, that all the 
other living organisms on the planet are, just as we, the current 
products of 3 billion years of evolution. Do we have the right 
to displace these, to replace them with products of human 
ingenuity? To make all the flora and fauna a human construct? 
And are we smart enough? Nature has evolved this remark-
ably self-sustaining, seemingly endlessly inventive biosphere, 
resilient, adaptive to the temporal variations of climate or 
volcanic activity, or even asteroid encounter. Can we do as 
well? 
We can undoubtedly acquire the knowledge to direct our 
own genetic destiny, but do we have the wisdom to effect such 
an undertaking to ends that are both sustainable and just? 
Biotechnology, this extraordinary accomplishment, by 
greatly extending the domain of human power, correspond-
ingly extends the scope of human responsibility. It thereby 
generates a need for new ethical principles to guide our 
conduct in this new world. 
Our varied human societies, culturally diverse, technically 
diverse, morally diverse, are but beginning to seek to cope 
with these issues. 
Accepted ethics are usually the result of the gradual accre-
tion of experience and wisdom in the conduct of human 
affairs. But it is clear that the simple extension of accepted 
ethics into this new domain will not be sufficient. What is not 
clear is whether the evolution of appropriate ethical princi-
ples can keep pace with the evolution of the technology. 
Human invention began slowly, back in pre-history with the 
use of fire and such remarkable creations as agriculture, the 
wheel, writing, and the alphabet. But, while cumulative, these 
were isolated events, separate in space and time. 
It was not until the late Renaissance, in the 16th and 17th 
centuries, that the idea arose of sustained exploration of 
Nature as in Frances Bacon's "House of Solomon"; the idea 
that mankind could, by continued discovery, come to under-
stand the world about us and then use that understanding, 
consciously, to shape the world to human needs and desires. 
It is amusing to realize that the entire staff of Bacon's 
proposed research facility was to be 33 persons. One of the 
major discoveries of this century has been that of the scale of 
scientific enterprise necessary, in many fields, to produce 
knowledge at a rate commensurate with the complexity oft he 
phenomena observed. Today, around the planet, literally mil-
lions of scientists are exploring Nature, and with tools of 
ever-increasing power and sophistication. 
And thus it is, in our time, that we are coming to understand 
that we need to use this great fund of knowledge with a 
corresponding degree of wisdom. And that this task -of selec-
tion, of the design of channels to guide the uses of our new 
profound knowledge of matter and life-is one of magnitude 
quite comparable to that needed to acquire this knowledge. 
We need to devise institutions, at the highest level , that can 
view these prospective innovations coherently in the broadest 
perspective. If we do not, then the social strains and the fears 
and stresses they engender may well ensnare us in a rigid net 
of regulation and process and deny us the great opportunities 
our discoveries offer. 
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